DZ

David Zawitz

Chief Operating Officer

Verrica Pharmaceuticals

Therapeutic Areas

Verrica Pharmaceuticals Pipeline

DrugIndicationPhase
YCANTH (VP-102)Molluscum ContagiosumApproved
VP-103Plantar WartsPre-IND
VP-315 (LTX-315)Basal Cell CarcinomaPhase 2
VP-315Squamous Cell CarcinomasPre-IND